您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Hemostatic Drugs and Hemocoagulase Report

讯：

Market Research Report on Hemostatic Drugs and Hemocoagulase
Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: 
Format:  Hardcopy and Adobe PDF 
Price:  US$1,960
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com 

The table of contents 
1 Categories and action mechanisms of Hemostatic Drugs
2 Market status of Hemostatic Drugs
  2.1 Theoretical market capacity
  2.2 Sales trend in the past 7 years
  2.3 Market shares of different categories in 2004
  2.4 Top breeds ranked by sales value
  2.5 Leading enterprises
3 Development and application of Hemocoagulase（Batroxobin）
  3.1 Overview of Hemocoagulase
  3.2 Progress of research and development
  3.3 Characteristic of molecule structure of Hemocoagulase
  3.4 Chemical properties of Hemocoagulase
  3.5 Pharmacologic action of Hemocoagulase
  3.6 Clinic usages of Hemocoagulase
4 Sales analysis of Hemocoagulase and Reptilase
  4.1 Sales analysis of hospital market of Hemocoagulase
     4.1.1 General sales trend
     4.1.2 Competing enterprises and region distribution
  4.2 Market share comparison  of Reptilase and BaQuTing（a kind of
 Hemocoagulase）
  4.3 Import status of Reptilase
  4.4 Marketing status of Reptilase and BaQuTing
  4.5 Overview of Reptilase in global market
5 Brief introduction of BaQuTing
6 Brief introduction of Snake Venom Enzyme of BaiMei Pallas Pit Viper 
(marketed by Jingzhou ChiTai biological company)
7 Brief introduction of "ZhiXieSu"（a kind of Hemocoagulase）
8 Slaes analysis of Aprotinin
  8.1 Brief introduction of Aprotinin
  8.2 Sales status of Aprotinin in hospital market
  8.3 Competing enterprises and region distribution
9 Enterprise shares of other Hemostatic Drugs
  9.1 Competing enterprises of tranexamic acid
  9.2 Competing enterprises of prothrombin complex
  9.3 Competing enterprises of thrombin
  9.4 Competing enterprises of human fibrinogen
  9.5 Competing enterprises of Carbazochrome
  9.6 Competing enterprises of Aminomethylbenzoic Acid
  9.7 Competing enterprises of Etamsylate